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SUMMARY
The incidence of nasopharyngeal carcinoma (NPC) varies widely according to age at diagnosis, geo-
graphic location, and ethnic background. On a global scale, NPC incidence is common among speciﬁc
populations primarily living in southern and eastern Asia and northern Africa, but in most areas, includ-
ing almost all western countries, it remains a relatively uncommon malignancy. Speciﬁc to these low-risk
populations is a general observation of possible bimodality in the observed age-incidence curves. We have
developed a multiplicative frailty model that allows for the demonstrated points of inﬂection at ages 15–24
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and 65–74. The bimodal frailty model has 2 independent compound Poisson-distributed frailties and gives
a signiﬁcant improvement in ﬁt over a unimodal frailty model. Applying the model to population-based
cancer registry data worldwide, 2 biologically relevant estimates are derived, namely the proportion of
susceptible individuals and the number of genetic and epigenetic events required for the tumor to develop.
The results are critically compared and discussed in the context of existing knowledge of the epidemiol-
ogy and pathogenesis of NPC.
Keywords: Carcinogenesis; Compound Poisson; Frailty; Nasopharyngeal carcinoma; Survival analysis.
1. INTRODUCTION
There are remarkable and well-deﬁned geographical and ethnic variations in the incidence of nasopharyn-
geal carcinoma (NPC) worldwide. Rates are high to intermediate in certain areas of south-eastern China,
southern Asia, northern Africa, and among Inuit populations of the Arctic region. With the exception of
migrant populations from high-risk areas, rates of this malignancy tend to be uniformly low elsewhere.
The aetiology of NPC is rather complex with causal pathways involving the Epstein–Barr virus (EBV) as
well as factors related to both the environment (often lifestyle related) and the host (genetic susceptibility)
(Chang and Adami, 2006; Hildesheim and Levine, 1993).
Age-incidence curves of certain cancers often exhibit a single peak in rates followed by a subsequent
decline. Among alternative explanations, this unimodality may be interpreted as a frailty phenomenon,
whereby most individuals are nonsusceptible to the disease, but a subset of individuals has an increased
risk at a given age. The risk at the population level must decline once those susceptible individuals have
acquired the disease, leaving the general population (at a given age) that is, in theory, nonsusceptible.
Frailty modeling provides an opportunity to take individual heterogeneity in disease susceptibility
into account. For reviews of frailty theory, see for example the introductions by Aalen (1988, 1994) or
Hougaard (2000). Frailty is an unobservable quantity modeled as a random variable over the population of
individuals, with a high (low) value of the frailty variable associated with a large (small) risk of acquiring
the disease. If the frailty variable is 0, the individual is nonsusceptible or ‘immune’.
The age-incidence curve of NPC for low-risk countries is somewhat atypical amongst cancer types. In
Bray and others (2008), it was shown that for most, if not all populations in this category, rates exhibit a
small peak within the age range 15–24, with rates steadily increasing to a second peak at ages 65–74 years,
andthendecliningsubsequently.Theaimsofthisstudywereﬁrstlytoidentifyafrailtymodelthatprovides
an adequate ﬁt to this more complex instance of bimodality in the age-incidence structure, secondly to
assess the signiﬁcance of the ﬁrst peak, and thirdly to interpret the resulting parameter estimates in the
context of the current epidemiologic and biological knowledge of NPC.
Using a number of published data sets from population-based cancer registries worldwide, we in-
clude 2 frailties, one per peak, and 2 basic rates in the multiplicative frailty model. The frailties are
assumed independent and compound Poisson distributed. This distribution has a discrete part of 0 frailty
(i.e. nonsusceptible) and a continuous part of positive frailties. Covariates are included in the underlying
Poisson parameters. We present the NPC hazard ratios by sex and geographical area in the analysis, to-
gether with 95% conﬁdence intervals for these ratios. The observed and estimated age-speciﬁc incidence
rates are plotted, and we examine the ﬁt of the bimodal frailty model. Estimates of the proportion of sus-
ceptible individuals and the number of genetic and epigenetic events required to attain malignancy are
given, with 95% conﬁdence intervals.
This paper is organized as follows: in Section 2, the data sources and the model are described, together
with some theoretical results. Section 3 presents the main results following application of the model to the
data. Finally, in Section 4, the assumptions of the model are stated, and the results are discussed in light
of our present understanding of the biology and aetiology of NPC.Frailty model for bimodal NPC incidence data 503
2. MATERIAL AND METHODS
2.1 Material
The Cancer Incidence in Five Continents (CI5) Vol. I to VIII ADDS database (Parkin and others, 2005)
was used to extract incident cases of nasopharyngeal cancer (ICD-10 C11) for 72 population-based cancer
registries, together with the corresponding population data by year of diagnosis, sex, and age. Although
all nasopharyngeal cancers were extracted, rather than only NPCs, the term NPC is used here to identify
carcinomas, given that they represent the vast majority of nasopharyngeal tumors, and the subset for which
most epidemiological studies have focused.
The inclusion and exclusion criteria are provided in detail in Bray and others (2008). Brieﬂy, we
restricted analyses to the period 1983–1997 and, to remove some of the inherent random variability, ex-
cluded populations with a mean annual coverage of less than 1 million inhabitants. For the remaining 23
registry populations, incidence data were available by eighteen 5-year age groups (0–4, 5–9, ..., 80–84,
85+) and sex for each of the years of diagnosis 1983–1997 (see footnotes of Table 1 for exceptions). Re-
gional registries were aggregated to national or larger area levels on the basis of geographical area, thus
enabling sufﬁcient numbers for meaningful age-speciﬁc analyses. Five aggregated low-risk areas were
deﬁned: North America, Japan, north and west Europe, Australia, and India. To examine the effect of
calendar time, the data were further divided into three 5-year diagnostic periods (1983–1987, 1988–1992,
1993–1997).
Table 1 gives an overview of the countries/regions included in the analysis, with the number of NPC
cases and corresponding number of person–years at risk (in millions) for males and females in the aggre-
gated areas in 1983–1997. In total, there were 6069 cases among males and 2697 among females. The
total number of person–years at risk (in millions) was 894.53 for males and 903.14 for females.
2.2 Statistical methods
Standard frailty theory makes use of the multiplicative frailty model. In this model, the individual hazard
rate is the product of an unobservable frailty variable Z and an unobservable basic rate λ(t) common to
all individuals; that is, h(t|Z) = Zλ(t) (Aalen, 1994), where t throughout denotes age. The population
hazard rate is the net result for a number of individuals with different frailties and is observable, as the age-
incidencerate.Thebasicratespeciﬁeshowthehazardchangeswithage.Thelevelofthehazardforagiven
individual is speciﬁed by the frailty which follows a speciﬁc statistical distribution. Common distributions
are the power variance function (PVF) distributions, which include the gamma and the compound Poisson
distribution as special cases.
To accommodate the bimodality in the age-incidence curve of NPC, we make a minor modiﬁcation
to the multiplicative frailty model by including 2 frailties, assumed for simplicity, to be independent. The
ﬁrst frailty, Z1, represents the risk of developing NPC in very early adulthood, postulated to be a result
of genetic and viral factors (Ayan and others, 2003). Later lifestyle factors (including smoking) probably
inﬂuence the risk of getting NPC for individuals aged 65–74 years, represented by the second frailty term,
Z2. We let the individual hazard rate be a linear combination of these 2 frailties,
h(t|Z1, Z2) = Z1λ1(t) + Z2λ2(t). (2.1)
NPC is a rare form of cancer, and to allow individuals to be nonsusceptible, we use the compound
Poisson distribution for the frailties Z1 and Z2. This distribution has been successfully applied to testicular
cancer and colorectal cancer (Aalen and Tretli, 1999; Moger and others, 2004; Svensson and others,
2006). For i = 1,2, let Xi,1, Xi,2,...,Xi,Ni be independent gamma-distributed random variables with504 M. HAUGEN AND OTHERS
Table 1. Number of NPC cases and corresponding number of person–years at risk (in millions) for males
and females in 1983–1997
Area Cases (M/F) Person–years (M/F)
North America 2705/1227 345.99/354.05
Canada
Surveillance Epidemiology and End Results white
Japan 587/232 80.67/83.21
Miyagi
Osaka
North and west Europe 1424/709 270.98/285.46
Denmark
Estonia
Switzerland, Z¨ uricha
UK, Birmingham and West Midlands
UK, Merseyside and Cheshire
UK, North western
UK, Oxfordb
UK, South Thames region
UK, Yorkshire
UK, Scotland
Australia 814/310 86.25/87.37
New South Wales
South
Victoria
India 539/219 110.63/93.04
Chennaic
Mumbaic
aIncidence data available for the years of diagnosis 1983–1996.
bIncidence data available for the years of diagnosis 1985–1997.
cPopulation data available in 16 age groups (0–4, 5–9, ..., 70–74, 75+).
scale and shape parameter νi and ηi, respectively. The frailty variables Z1 and Z2 are given by
Zi =
 
Xi,1 + Xi,2 + ···+Xi,Ni, if Ni > 0,
0, if Ni = 0,
i = 1,2,
where Ni is a Poisson-distributed random variable with expectation ρi. The Poisson parameters ρi (i =
1,2) determine the proportion of nonsusceptible individuals as P(Zi  = 0) = 1 − exp(−ρi).
Theage-speciﬁcincidenceratesofNPCvarybysexandgeographiclocationand,insomepopulations,
with time. Hence, we allowed ρi to change over sex, area, and diagnostic period by including covariates
in this parameter. The Poisson parameters can therefore be written as
ρi = exp
⎛
⎝ρ0i + β1i · sex +
4  
j=1
β2ij · areaj +
2  
k=1
β3ik · diagk
⎞
⎠, i = 1,2. (2.2)
The process of carcinogenesis can be described by different multistage models, among which the
Armitage–Doll (AD) multistage model (Armitage and Doll, 1954) is well known. In this model, cellsFrailty model for bimodal NPC incidence data 505
go through an irreversible process, transforming normal cells into malignant cells via many intermedi-
ate states. The AD model does not take into account that cells can replicate, die, or differentiate. The
Moolgavkar–Venzon–Knudson (MVK) model is a 2-stage model which allows for clonal expansion of
intermediate cells. Both these multistage models are illustrated in Portier and Kopp-Schneider (1991),
who also give an expansion of the MVK model to include DNA damage, cell replication, and DNA repair,
the damage-ﬁxation multistage model. Little (1995) proposes a generalization of the MVK model which
allows an arbitrary number of mutational stages.
Armitage and Doll (1954) justify the use of the Weibull distribution for the basic rates, while Kopp-
Schneider (1997) states that the Weibull model is the most commonly used parametric model for carcino-
genesis. If we let k be the shape parameter of this distribution, we obtain that λi(t) = kitki−1, i = 1,2.
Usually these hazard rates are written as aikitki−1, where the as are scale parameters. To avoid
overparameterization, these parameters are subsumed in the frailty variables, that is, a1 = a2 = 1.
The individual survival function, given the frailties, is S(t|Z1, Z2) = exp(−Z1 1(t) − Z2 2(t)),
where  i(t) =
  t
0 λi(s)ds = tki, i = 1,2, are the cumulative basic rates. If we integrate out the unknown
frailty variables, we get the population survival function
S(t) = E [S(t|Z1, Z2)]
= exp
 
−ρ1
 
1 −
 
ν1
ν1 +  1(t)
 η1 
− ρ2
 
1 −
 
ν2
ν2 +  2(t)
 η2  
. (2.3)
By differentiating the natural logarithm of (2.3) with respect to t and changing the sign, we ﬁnd the
population hazard rate
h(t) = ρ1ν−1
1 η1
 
ν1
ν1 +  1(t)
 η1+1
λ1(t) + ρ2ν−1
2 η2
 
ν2
ν2 +  2(t)
 η2+1
λ2(t). (2.4)
The function in (2.4) is bimodal, as opposed to the individual hazard rate in (2.1) which is monotonic.
It is an expansion of the population hazard rate given in Aalen and Tretli (1999). With only one peak in the
age-incidence curve, only one of the terms in (2.4) would have been necessary. The Poisson parameter ρ
wouldhavebeenaproportionalityfactor,andincludingcovariatesinthisparameteronlywouldhavegiven
a proportional hazards model. However, it is possible for ρ1 and/or ρ2 to be proportionality parameters
also in the bimodal model. Figure 1(a) shows an example of the hazard function in (2.4). The plot in
Figure 1(b) shows the population hazard rates for the 2 peaks separately, that is, for the 2 terms in (2.4).
We see that these hazard rates increase up to a certain age after which the curves start to decrease. If we
add these hazard rates together, we get the bimodal curve in Figure 1(a). The ﬁrst peak (from Z1)i nt h e
bimodal curve decreases less than the long-dashed line in Figure 1(b), but the second peak (from Z2)i s
in accordance with the dashed line in Figure 1(b). At all ages where one of the 2 curves is approximately
0, the corresponding term in (2.4) will cancel out. Hence, in this example the Poisson parameter ρ2 is a
proportionality factor at, for example, the second peak since the frailty Z1 is 0 at this age, but this will not
be the case for ρ1 at the ﬁrst peak where both Z1 and Z2 contribute to the total curve.
The parameters for the frailty distributions and the basic rates are assumed equal for both sexes in all
age intervals, areas, and diagnostic periods. From (2.4), we see that the population hazard rates for males
and females in area j and diagnostic period k (denoted later as hMjk(t) and hFjk(t), respectively) differ
only in the values of the Poisson parameters. Let ρiMjk and ρiFjk be the Poisson parameters for males
and females, respectively, in peak i, area j, and diagnostic period k. Further let
Ai(t) = ν−1
i ηi
 
νi
νi +  i(t)
 ηi+1
λi(t), i = 1,2, (2.5)506 M. HAUGEN AND OTHERS
Fig. 1. Bimodal population hazard rate in (a) (2.4) for certain parameter values. Hazard function for each of the
2 peaks separately in (b), same parameter values as in (a).
be the parts of the population hazard rate in (2.4) that are equal for the sexes in all age intervals, areas,
and diagnostic periods. Combining (2.4) and (2.5), the hazard ratio between males and females in area j
and diagnostic period k becomes
HRMF(t) =
hMjk(t)
hFjk(t)
=
ρ1Mjk · A1(t) + ρ2Mjk · A2(t)
ρ1Fjk · A1(t) + ρ2Fjk · A2(t)
. (2.6)
The hazard ratio between males in area j and reference area j , in the same diagnostic period k,i s
given by
HRMM(t) =
hMjk(t)
hMj k(t)
=
ρ1Mjk · A1(t) + ρ2Mjk · A2(t)
ρ1Mj k · A1(t) + ρ2Mj k · A2(t)
. (2.7)
The hazard ratios in (2.6) and (2.7) depend on age. They are quite complex because the population
hazard rate in (2.4) consists of 2 terms, so generally we cannot cancel out common terms. Parametric
bootstrapping is required to obtain corresponding conﬁdence intervals.Frailty model for bimodal NPC incidence data 507
The proportion of susceptible individuals follows from the underlying Poisson parameters. Speciﬁ-
cally, the probabilities of the individual being susceptible in peak 1 and peak 2 are 1 − exp(−ρ1) and
1 − exp(−ρ2), respectively.
2.3 Estimation procedure
The method is the same as in Aalen and Tretli (1999). Let µjklm and Rjklm be, respectively, the expected
and the observed number of NPC cases in area j, diagnostic period k, and age interval l for sex m. Let
Tjklm be the corresponding number of person–years at risk. From a Poisson model, the likelihood function
is given by
L =
5  
j=1
3  
k=1
L j  
l=1
2  
m=1
µ
Rjklm
jklm exp(−µjklm).
The midpoints of the age intervals are denoted by t1,...,t16 or t1,...,t18, depending on the number
of age groups. The expected number of NPC cases is deﬁned as the average hazard rate per year for area j,
diagnostic period k, age interval l, and sex m, multiplied by the number of person–years,
µjklm = Tjklm[ln(S(tl−1)) − ln(S(tl))]/5.
The likelihood function depends on the parameters through the population survival function given in
(2.3). We assume that the Weibull shape parameters ki and the scale and shape parameters νi and ηi of
the underlying gamma distributions are the same for both sexes in all age intervals, areas, and diagnostic
periods. This gives the same shape of the distributions to reduce the number of parameters. The Poisson
parameters ρi (i = 1,2) are allowed to change over sex, area, and diagnostic period according to (2.2).
This gives 11 parameters per peak and a total of 22 parameters in the model, which we estimate by
maximizing the natural logarithm of the likelihood function, ln(L). The R function “nlminb” is used for
the maximization, and standard errors are calculated from the Hessian matrix in the R function “optim.”
The parameter estimate divided by the standard error of this estimate gives the Wald test, which is used to
test the effect of the covariate by computing 2-sided p-values.
The conﬁdence intervals for the hazard ratios are based on the percentile method. This method uses
the α/2 and 1 − α/2 percentiles of the bootstrap sample, in ascending order, if α(B + 1) is an integer
(Carpenter and Bithell, 2000). For simplicity, we use B = 999 and a signiﬁcance level α = 0.05.
3. RESULTS
The reference level for the covariate diagnostic period is 1983–1987. Two-sided p-values for the test of
no effect of this covariate in peak 1, adjusted for the covariates sex and area, are 0.25 and 0.24 for the
periods 1988–1992 and 1993–1997, respectively. For the second peak, the p-values are 0.14 and 0.09.
Hence, there is no signiﬁcant difference in the age incidence for the three 5-year diagnostic periods. In the
following, we therefore analyze data for the aggregated 15-year diagnostic period 1983–1997.
The left part of Table 2 shows the 2-sided p-values for the test of no effect of the covariates sex and
area, unadjusted for diagnostic period. For these covariates, Table 2 also gives the hazard ratios, as given in
(2.6) and (2.7), at the mean value of the age intervals for the 2 peaks (t = 19.5 and t = 69.5, respectively)
with 95% bootstrap conﬁdence intervals. The conﬁdence intervals are much wider at age 19.5 than at
age 69.5 because of fewer cases. The covariate sex is signiﬁcant in both peaks with an increased risk for
males compared to females. Corresponding to the example in Figure 1, both terms in (2.6) contribute to
the hazard ratio at age 19.5, and the effect of sex therefore depends on area of residence. We present the
mean hazard ratio over areas to get one combined estimate of 1.89 with (1.50, 2.20) as the 95% conﬁdence508 M. HAUGEN AND OTHERS
Table 2. P-values for both peaks and hazard ratios at ages t = 19.5 (mean of age interval peak 1) and
t = 69.5 (mean of age interval peak 2) with 95% bootstrap conﬁdence intervals of sex and area
P-value HR(19.5) HR(69.5)
Peak 1 Peak 2
Sex. Reference level: women
Sex <0.001 <0.001 1.89 [1.50,2.20] 2.56 [2.53,2.74]
Area. Reference level: North America
Japan 0.45 <0.001 1.02 [0.63,1.23] 0.81 [0.79,0.85]
N/W Europe 0.81 <0.001 0.86 [0.64,0.97] 0.59 [0.58,0.60]
Australia 0.07 <0.001 1.29 [1.13,1.84] 1.13 [1.06,1.15]
India <0.001 <0.001 1.83 [1.30,2.09] 0.84 [0.79,0.90]
interval. At age 69.5, the hazard ratio for sex is 2.56 (2.53,2.74) regardless of area, as the ﬁrst hazard in
(2.6) is approximately 0 at this age. In most areas from which data are available, the reported male:female
ratio in the population of individuals who acquire the disease is in the range of 2–3:1 (Hildesheim and
Levine, 1993).
Correspondingly, for the area covariate, we present the mean hazard ratio over sex at age 19.5. From
the p-values and the hazard ratios, India is the only area with a signiﬁcantly higher risk than North
America at the ﬁrst peak. The other possible differences are not signiﬁcant according to the Wald test,
though unity is not included in the conﬁdence interval for north and west Europe and Australia. The
results for these 2 tests differ because the hazard ratio in (2.7) is inﬂuenced by the parameters in both
peaks. The function A2(t) in (2.5) is approximately 0 for small values of t, but this is not the case for
t = 19.5. At the second peak (age 69.5), we see signiﬁcant differences between North America and all
the 4 other areas. The 95% conﬁdence intervals support this conclusion; the difference for individuals
aged 69.5 years is signiﬁcant. For t = 69.5, the hazard ratio is mostly inﬂuenced by the parameters in
the second peak since the function A1(t) in (2.5) is approximately 0 for large values of t. This results in
consistent results from p-values and hazard ratios. North America has a higher risk than all the other areas
except Australia.
Figure 2 presents 25 bootstrap age-incidence curves, used to calculate bootstrap conﬁdence intervals,
together with the observed values. The estimated incidence rates are given by replacing the parameters
in (2.4) with their estimated values. These graphs are presented on a semilog-scale to highlight the bi-
modality. We see less variation for North America than Japan, especially up to the ﬁrst peak, and the ﬁt
is also somewhat better for the former area. This is expected as North America has the highest number of
person–years at risk and Japan the lowest (see Table 1). North America contributes therefore the most to
the likelihood function and hence the parameter estimates.
The estimates of the other parameters in the compound Poisson model are given in Table 3. The
underlying Weibull hazard rate has a shape parameter of 2.48 with 95% conﬁdence interval (2.16,2.80)
for the ﬁrst peak and 4.65 (4.28,5.03) for the second. These conﬁdence intervals are based on a normal
approximation and are calculated from the estimates and standard errors in Table 3. Note that exp(β) for
the second peak is equal to the hazard ratios given in the last column of Table 2, since the underlying
Poisson parameter ρ2 given in (2.2) is a proportionality factor.
To check the improvement in goodness of ﬁt for a bimodal model over a unimodal model, we also
ﬁtted a standard unimodal compound Poisson frailty model with a Weibull baseline hazard to the data.
This model has a total of 9 parameters and yielded a log-likelihood of 30067.52. The bimodal model
yielded a log-likelihood of 30372.82, a signiﬁcant improvement over the single-peaked model by theFrailty model for bimodal NPC incidence data 509
Fig. 2. Observed (discrete points) and 25 bootstrap (continuous curves) age-speciﬁc incidence rates per 100000
person–years for both sexes in North America and Japan. Vertical lines are included to emphasize the rates in age
groups 15–24 and 65–74.
likelihood ratio test (p-value < 0.001). A comparison of the observed and estimated incidence rates for
these models illustrate this; in Figure 3, graphs of rates versus age are presented on a semilog-scale. The
modiﬁed multiplicative frailty model provides an acceptable ﬁt to the data, and we can clearly see the
improvement over the unimodal ﬁt. Again, we see a better ﬁt for North America and north and west
Europe than for the other areas.510 M. HAUGEN AND OTHERS
Table 3. Maximum likelihood estimates with standard errors of the parameters
Parameters νη k ρ0
Peak 1
Estimates 2.81 × 104 23.48 2.48 −11.32
se 4.33 × 104 36.70 0.16 0.15
Peak 2
Estimates 6.16 × 108 1.39 4.65 −7.54
se 2.19 × 108 0.95 0.19 0.12
Parameters β1 β21 β22 β23 β24
Peak 1
Estimates 0.50 0.15 0.03 0.34 0.92
se 0.10 0.20 0.14 0.18 0.13
Peak 2
Estimates 0.94 −0.21 −0.52 0.12 −0.17
se 0.02 0.04 0.03 0.04 0.05
se, standard error.
In Figure 4, we have plotted the estimated proportion of susceptible males and females per 100000
person–years, with error bars giving the 95% conﬁdence intervals. These intervals are log transformed
since the proportions of susceptible individuals are relatively small and the coefﬁcients of variation for
these values are relatively large. In all 5 aggregated low-risk areas, for both peaks, there is a higher frailty
proportion among males than females, reﬂecting the higher incidence among males. In peak 1, North
America has the lowest proportion of frail individuals and India the highest. The hazard ratio at age
19.5 gave signiﬁcantly higher risk for India than North America. North and west Europe has the lowest
proportion of frail individuals and Australia the highest in the second peak.
4. DISCUSSION
The principal ﬁnding of the present study is that NPC incidence rates in low-risk populations are well
described by a bimodal frailty model in both males and females diagnosed over the period 1983–1997.
It is necessary to discuss the relevance of the assumptions of the model since other models built on an
alternative set of assumptions may also ﬁt the data.
The key assumption of a frailty model implies that only a certain proportion of individuals are sus-
ceptible to develop NPC at a given age during their lifetime. Both genetic and environmental factors
contribute to the development of this disease. The link between the NPC and the EBV is well known
(Chang and Adami, 2006; Hildesheim and Levine, 1993). EBV belongs to the herpes virus family and
is one of the most common human viruses. This virus is ubiquitous worldwide, and many individu-
als are infected during their lifetime. Only a small proportion of individuals develop NPC, however,
so EBV is not a sufﬁcient cause of NPC. In high-risk populations where undifferentiated carcinomas
or lymphoepitheliomas (Type-I NPC tumors) are common, genetic events appear to occur early in NPC
pathogenesis and may cause predisposition to subsequent EBV infection. It may be speculated that EBV
is a necessary factor for those histological types of NPC where stable infection of epithelial cells
by EBV requires such an altered, undifferentiated cellular environment (Lo and Huang, 2002
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Fig. 3. Observed (discrete points) and estimated (continuous curves) age-speciﬁc incidence rates per 100000 person–
years for both sexes in 5 low-risk areas. Solid (dashed) line is from a bimodal (unimodal) ﬁt. Vertical lines are included
to emphasize the rates in age groups 15–24 and 65–74.
In the low-risk settings studied here, however, type-III tumors—keratinizing squamous cell
carcinomas—dominate, particularly at older ages (the late peak in age incidence), and there is an incon-
sistent relationship between the EBV infection and the development of these tumors (Chang and Adami,
2006).
Genetic and/or other environmental cofactors must additionally contribute to the risk of NPC. The
ﬁrst peak in individuals diagnosed in late adolescence or early adulthood would imply a role for germline
mutations (major genes) and gene polymorphisms (minor genes), see Chan and others (2005) and Bray
and others (2008). EBV infection seems likely to contribute to NPC in this young age group (Ayan
and others, 2003), where type-III cancer is the more commonly diagnosed type (linked with the early
peak in age incidence). The second later peak relates more to lifestyle-related risk determinants, including
tobacco and alcohol consumption and, more speculatively, occupational exposures to carcinogens, such
as formaldehyde (Chang and Adami, 2006).
Another assumption of our model is independence between frailties. This assumption provides a
simpliﬁcation of the model, as with the population survival function in (2.3). Usually, bimodal age-
incidence curves are the integrated effect of the 2 different underlying unimodal population distributions,
corresponding to the early and late peak. In such cases, the 2 distributions tend to represent different
aetiologies, as discussed for Hodgkin’s lymphoma (MacMahon, 1966). In this instance, it seems rea-
sonable that the 2 peaks of the NPC age-incidence curves differ substantially in terms of aetiology. This512 M. HAUGEN AND OTHERS
Fig. 4. Estimated proportion of susceptible males and females per 100 000 person–years (circles) in (a) peak 1 and
(b) peak 2. The error bars give the log-transformed 95% conﬁdence intervals.
argument,togetherwiththefactthatthedistancebetweentheageintervalsforthepeaksislarge,makesthe
assumption of independence sensible. If EBV infection is a common factor in the pathway of both pop-
ulations, the shape of the age-incidence curves may also be inﬂuenced by the timing of events including
age at infection, speciﬁc genetic events, and, possibly, environmental exposures.
The underlying assumption of the frailty modeling is the mechanistic understanding of cancer as a
result of accumulated genetic damage, generally regarded as the multistage clonal expansion model of
carcinogenesis. The biological interpretation of the k parameter is the number of genetic and epigenetic
events required on average for a cell to become malignant (Armitage and Doll, 1954), although this in-
terpretation should be suitably cautious for more complex multistage models. In previous frailty model
studies, the estimated parameter values have been in accordance with current knowledge regarding car-
cinogenesis of the speciﬁc neoplasm, that is, testicular cancer (Aalen and Tretli, 1999) and colorectal
cancer (Svensson and others, 2006). In the current study, the estimated k-values of 2.5 and 4.7 for the ﬁrst
and second peak, respectively, compare with a k-value of 3.0 from a previous simulation study on a sam-
ple of low-risk western populations reported by Doll (1971). At this time, the uniformity of bimodality
among NPC cases in low-risk populations was certainly not recognized, and Doll’s estimate (assuming a
unimodal distribution) lies between our estimates derived using a bimodal distribution.Frailty model for bimodal NPC incidence data 513
The k parameter of 2–3 for the early peak in the age-incidence curve may be interpreted biologically
as a reﬂection of the 2 crude ‘hits’ in the carcinogenesis, that is, the genetic alterations involving major or
minor susceptibility genes and a promoting effect of EBV infection. The pathogenesis leading to the late
peak in the age-incidence curve is thought to be related more to the effect of environmental carcinogens
possibly interacting with EBV infection. This is illustrated in Figure 4 of Bray and others (2008). It is
quite plausible that environmental cofactors in the population as a whole may provide (on average) 2 more
‘hits’, for example, loss of heterozygosity in certain genes and/or other genetic changes as described by
Young and Rickinson (2004) and Chan and others (2005).
Earlier studies have concluded that the incidence of NPC in the population of individuals who acquire
the disease is 2- to 3-fold higher in males than females (Chang and Adami, 2006; Hildesheim and Levine,
1993). We have found a similar increased risk for males up to the second peak (t = 69.5 years) compared
to females. A general explanation could be the tendency for less favorable smoking and alcohol consump-
tion patterns among males. The close to doubling of risk for susceptible individuals among males up to
the ﬁrst peak (t = 19.5 years) is intriguing but not readily explained given present knowledge.
Finally, the bimodal frailty model developed in this paper was applied to NPC age incidence to ex-
amine susceptibility among low-risk populations. However, the model may be applied to any disease
condition where the bimodality of the age-occurrence pattern can be demonstrated at the population level.
For cancer, such a phenomenon is not unique to NPC; there are a number of cancer forms that exhibit
2 peaks in incidence rates followed by respective declines subsequently, and a frailty approach to their
study would certainly seem warranted. Examples from cancer often involve a putative early viral com-
ponent. These include Hodgkin’s lymphoma, which has long been established as bimodal (MacMahon,
1966), with a relatively high proportion of cases occurring in adolescents and young adults, particularly in
higher-resource countries. More recent candidates include hairy cell leukaemia (Dores and others, 2008),
female breast carcinoma (Anderson and others, 2006), and Ewing’s sarcoma (Cope, 2000).
ACKNOWLEDGMENTS
We are grateful to the population-based cancer registries worldwide that submitted their data to successive
volumes of Cancer Incidence in Five Continents. The authors thank Bjarte Aagnes at the Cancer Registry
of Norway for providing the data. Conﬂict of Interest: None declared.
FUNDING
Statistics for Innovation (sﬁ)2 to M.H.
REFERENCES
AALEN, O. O. (1988). Heterogeneity in survival analysis. Statistics in Medicine 7, 1121–1137.
AALEN, O. O. (1994). Effects of frailty in survival analysis. Statistical Methods in Medical Research 3, 227–243.
AALEN,O .O .AND TRETLI, S. (1999). Analyzing incidence of testis cancer by means of a frailty model. Cancer
Causes and Control 10, 285–292.
ANDERSON,W .F .,P FEIFFER,R.M.,D ORES,G.M.ANDSHERMAN, M. E. (2006).Comparisonofagedistribution
patterns for different histopathologic types of breast carcinoma. Cancer Epidemiology, Biomarkers & Prevention
15, 1899–1905.
ARMITAGE,P .AND DOLL, R. (1954). The age distribution of cancer and a multi-stage theory of carcinogenesis.
British Journal of Cancer 8, 1–12.514 M. HAUGEN AND OTHERS
AYAN,I . ,K AYTAN,E .AND AYAN, N. (2003). Childhood nasopharyngeal carcinoma: from biology to treatment.
Lancet Oncology 4, 13–21.
BRAY,F . ,H AUGEN,M . ,M OGER,T .A . ,T RETLI,S . ,A ALEN,O .O .AND GROTMOL, T. (2008). Age-incidence
curves of nasopharyngeal carcinoma worldwide: bimodality in low-risk populations and aetiologic implications.
Cancer Epidemiology, Biomarkers & Prevention 17, 2356–2365.
CARPENTER,J .AND BITHELL, J. (2000). Bootstrap conﬁdence intervals: when, which, what? A practical guide for
medical statisticians. Statistics in Medicine 19, 1141–1164.
CHAN,J .K .C . ,B RAY,F . ,M CCARRON,P . ,F OO,W . ,L EE,A .W .M . ,Y IP,T . ,K UO,T .T . ,P ILCH,B .Z . ,
WENIG,B .M . ,H UANG,D .and others (2005). Nasopharyngeal carcinoma. In: Barnes, E. L., Eveson, J. W.,
Reichart, P. and Sidransky, D. (editors). Pathology and Genetics of Head and Neck Tumours. Kleihues, P. and
Sobin, L. H. (series editors). World Health Organization Classiﬁcation of Tumours. Lyon, France: IARC Press,
pp. 85–97.
CHANG,E .T .AND ADAMI, H.-O. (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer
Epidemiology, Biomarkers & Prevention 15, 1765–1777.
COPE, J. U. (2000). A viral etiology for Ewing’s sarcoma. Medical Hypotheses 55, 369–372.
DOLL, R. (1971). The age distribution of cancer: implications for models of carcinogenesis. Journal of the Royal
Statistical Society, Series A (General) 134, 133–166.
DORES,G .M . ,M ATSUNO,R .K . ,W EISENBURGER,D .D . ,R OSENBERG,P .S .AND ANDERSON, W. F. (2008).
Hairy cell leukaemia: a heterogeneous disease? British Journal of Haematology 142, 45–51.
HILDESHEIM,A .AND LEVINE, P. H. (1993). Etiology of nasopharyngeal carcinoma: a review. Epidemiologic
Reviews 15, 466–485.
HOUGAARD, P. (2000). Analysis of Multivariate Survival Data. New York: Springer.
KOPP-SCHNEIDER, A. (1997). Carcinogenesis models for risk assessment. Statistical Methods in Medical Research
6, 317–340.
LITTLE, M. P. (1995). Are two mutations sufﬁcient to cause cancer? Some generalizations of the two-mutation
model of carcinogenesis of Moolgavkar, Venzon, and Knudson, and of the multistage model of Armitage and
Doll. Biometrics 51, 1278–1291.
LO,K . - W .AND HUANG, D. P. (2002). Genetic and epigenetic changes in nasopharyngeal carcinoma. Seminars in
Cancer Biology 12, 451–462.
MACMAHON, B. (1966). Epidemiology of Hodgkin’s disease. Cancer Research 26, 1189–1200.
MOGER,T .A . ,A ALEN,O .O . ,H EIMDAL,K .AND GJESSING, H. K. (2004). Analysis of testicular cancer data
using a frailty model with familial dependence. Statistics in Medicine 23, 617–632.
PARKIN,D .M . ,W HELAN,S .L . ,F ERLAY,J .AND STORM, H. (2005). Cancer Incidence in Five Continents, Vol I
to VIII, IARC CancerBase No. 7. Lyon, France: IARC Press.
PORTIER,C .J .AND KOPP-SCHNEIDER, A. (1991). A multistage model of carcinogenesis incorporating DNA dam-
age and repair. Risk Analysis 11, 535–543.
SVENSSON,E . ,M OGER,T .A . ,T RETLI,S . ,A ALEN,O .O .AND GROTMOL, T. (2006). Frailty modelling of col-
orectal cancer incidence in Norway: indications that individual heterogeneity in risk is related to birth cohort.
European Journal of Epidemiology 21, 587–593.
YOUNG,L .S .AND RICKINSON, A. B. (2004). Epstein-Barr virus: 40 years on. Nature Reviews Cancer 4, 757–768.
[Received July 9, 2008; ﬁrst revision November 3, 2008; second revision January 29, 2009;
accepted for publication February 23, 2009]